Antitubercular drugs: possible role of natural products acting as antituberculosis medication in overcoming drug resistance and drug-induced hepatotoxicity

被引:0
作者
Harvesh Kumar Rana
Amit Kumar Singh
Ramesh Kumar
Abhay K. Pandey
机构
[1] University of Allahabad,Department of Biochemistry
[2] Feroze Gandhi College,Department of Zoology
[3] BMK Government. Girls College,Department of Botany
[4] Central University of Punjab,Department of Biochemistry
关键词
Tuberculosis; Drug-resistance; Hepatoprotective; Natural products; Liver injury;
D O I
暂无
中图分类号
学科分类号
摘要
Mycobacterium tuberculosis (Mtb) is a pathogenic bacterium which causes tuberculosis (TB). TB control programmes are facing threats from drug resistance. Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mtb strains need longer and more expensive treatment with many medications resulting in more adverse effects and decreased chances of treatment outcomes. The World Health Organization (WHO) has emphasised the development of not just new individual anti-TB drugs, but also novel medication regimens as an alternative treatment option for the drug-resistant Mtb strains. Many plants, as well as marine creatures (sponge; Haliclona sp.) and fungi, have been continuously used to treat TB in various traditional treatment systems around the world, providing an almost limitless supply of active components. Natural products, in addition to their anti-mycobacterial action, can be used as adjuvant therapy to increase the efficacy of conventional anti-mycobacterial medications, reduce their side effects, and reverse MDR Mtb strain due to Mycobacterium’s genetic flexibility and environmental adaptation. Several natural compounds such as quercetin, ursolic acid, berberine, thymoquinone, curcumin, phloretin, and propolis have shown potential anti-mycobacterial efficacy and are still being explored in preclinical and clinical investigations for confirmation of their efficacy and safety as anti-TB medication. However, more high-level randomized clinical trials are desperately required. The current review provides an overview of drug-resistant TB along with the latest anti-TB medications, drug-induced hepatotoxicity and oxidative stress. Further, the role and mechanisms of action of first and second-line anti-TB drugs and new drugs have been highlighted. Finally, the role of natural compounds as anti-TB medication and hepatoprotectants have been described and their mechanisms discussed.
引用
收藏
页码:1251 / 1273
页数:22
相关论文
共 1065 条
  • [71] Mur LAJ(2013) Through Casual Contact With an Infectious Case Am J Respir Crit Care Med 188 858-966
  • [72] Barua N(2020)Antimicrobial, antitubercular and antiproliferative activities of quercetin isolated from the marine Stem Extracts. Medicines 7 11-2193
  • [73] Buragohain AK(2019). Bangladesh Phytomed 60 459452-2195
  • [74] Beckert P(2014)Molecular mechanisms underlying chemical liver injury BioMed Res Int 2014 4457-71
  • [75] Hillemann D(2015)Antioxidant and antidiabetic activities of Antimicrob Agents Chemother 59 2087-S40
  • [76] Kohl TA(2010) fruit in alloxan-induced diabetic rats J Appl Microbiol 109 1-1106
  • [77] Kalinowski J(2011)Aceclofenac-induced hepatotoxicity: An ameliorative effect of Tuberculosis 91 447-e00917
  • [78] Richter E(2012) fruit and ellagic acid Antonie van Leeuwenhoek 102 3409-351
  • [79] Niemann S(2006)Probing the Interaction of the Diarylquinoline TMC207 with Its Target Mycobacterial ATP Synthase J Clin Microbiol 44 978-171
  • [80] Feuerriegel S(2020)Reassessing the Host Defense Peptide Landscape Crit Rev Biotechnol 40 279-49